Skip to main content

Table 3 Cost-effectiveness analysis of thermotherapy vs. glucantime

From: Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia

Strategy

C

IC

E

IE

IC/IE

Dominance

CEA

DALYs averted

 Thermotherapy

290,187

–

140.75

 

–

–

2062

 Glucantime

508,797

218,610

119.99

−20.76

−10,530

Dominated

4241

Patients Cured

 Thermotherapy

290,187

–

4124

–

–

–

70,4

 Glucantime

508,797

218,610

6016

1892

115,5

–

84,6

  1. C cost, IC incremental cost, E effectiveness, IE incremental effectiveness, CEA cost effectiveness average
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us